| Mrs Jean Ann Fornwalt, LPN | |
|
201 Chestnut Ave, Altoona, PA 16601-4927 | |
| (814) 946-5411 | |
| Not Available |
| Full Name | Mrs Jean Ann Fornwalt |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 201 Chestnut Ave, Altoona, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609190511 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | PN28033 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jean Ann Fornwalt, LPN 201 Chestnut Ave, Altoona, PA 16601-4927 Ph: (814) 946-5411 | Mrs Jean Ann Fornwalt, LPN 201 Chestnut Ave, Altoona, PA 16601-4927 Ph: (814) 946-5411 |
News Archive
The microbiome is the collection of microorganisms that colonize the human body. Dr. Jasmohan Bajaj discusses the relationship between the microorganisms in the gut and cirrhosis, and how microbiome analysis can be used to predict the risk of cirrhosis-associated hospitalizations.
The introduction of laws banning smoking in public places and workplaces in North America and Europe has had a positive impact on child health.
It's the most common bacteria-related sexually transmitted disease in the United States, so researchers at The University of Texas at San Antonio's South Texas Center for Emerging Infectious Diseases (STCEID) and The University of Texas at San Antonio Health Science Center have partnered to discover a vaccine that will prevent Chlamydia.
Research led by University of Birmingham scientists has found that people suffering from the adrenal disorder known as Addison's disease suffer from an immune system defect which makes them prone to potentially deadly respiratory infections.
GlaxoSmithKline plc and Genmab A/S announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License Application (sBLA) for the use of Arzerra® (ofatumumab), a CD20-directed cytolytic monoclonal antibody, in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate.
› Verified 4 days ago
Mrs. Tina Marie Mccall, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1614 Sharp Ave, Altoona, PA 16601 Phone: 814-329-3696 | |
Casey Sabella, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2907 Pleasant Valley Blvd, Altoona, PA 16602 Phone: 877-626-2500 | |
Rhonda Bumbaugh, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 Chestnut Ave, Altoona, PA 16601 Phone: 814-946-5411 | |
Tracy Vance, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 Chestnut Ave, Altoona, PA 16601 Phone: 814-946-5411 | |
Deanna Dunn, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 Chestnut Ave, Altoona, PA 16601 Phone: 814-946-5411 | |
Ashley Eastep, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 E Chestnut Ave, Altoona, PA 16601 Phone: 814-943-0414 | |
Miss Lisa Nicole Prough, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 201 Chestnut Ave, Altoona, PA 16601 Phone: 814-946-5411 |